Russian company starts to sell Longidaze in Uzbekistan
06/07/2015 16:38
Russian company starts to sell Longidaze in Uzbekistan
06/07/2015 16:38
Tashkent, Uzbekistan (UzDaily.com) -- NPO Petrovax Pharm (Russia) expanded a line of products, supplied to Uzbekistan, in June 2015 and carried out first export of Longidaze medicament to the Central Asian state.
Longidaze is an innovative product with proven effectiveness in prevention and combination therapy of connective tissue hyperplasia (commissures, fibrosis and fibrotic granulomas, scars).
During six years of research, clinical trials, and clinical use, the drug has proven its high therapeutic effectiveness and safety in pulmonology, urology, gynaecology, orthopaedics, surgery, cosmetology, dermatology and venereology, and otolaryngology.
Elena Arkhangelskaya, President of NPO Petrovax Pharm, said that the volume of exports to Uzbekistan has grown five time since 2010, when the company entered the Uzbek market. She said that the company sees perspectives for further development as Uzbekistan is attractive market with high export potential.
She noted that the Russian company started to sell another perspective medicament, which will help many women to become mothers.
NPO Petrovax Pharm started to exports its medicaments to Uzbekistan in 2010. It exported Polyoxidonium to Uzbekistan. The company said it is planning to start to export ant-flu vaccine Grippol Plus to Uzbekistan.
19/05/2024Read more
19/05/2024Read more
$ 1 | 12727.96 | +0.134% |
1 | 13781.84 | +0.459% |
₽ 1 | 139.46 | +0.288% |